Did not become law. It stopped in the Senate's Appropriations Committee on March 10, 2017. The 2017 session has ended.
2017 Regular Session
Senate Bill 21
AN ACT CONCERNING HEALTH INSURANCE COVERAGE OF ORALLY AND INTRAVENOUSLY ADMINISTERED MEDICATIONS.
What it does
The synopsis the General Assembly published with the bill.
To require health insurance policies that provide coverage for prescription drugs to provide coverage for intravenously administered drugs on a basis no less favorable than orally administered drugs.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
Its course
January 9 to March 10, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action10 actions on 9 days
In the SenateJan 9 to Mar 10 · stopped60 days
Insurance and Real Estate CommitteeJan 9 to Mar 757 days
Appropriations CommitteeMar 7 to Mar 10 · stopped3 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the Senate Jan 9 – Mar 7
- Jan 9Introduced and sent to Insurance and Real Estate Committee
- Feb 2Heard in Insurance and Real Estate Committee
- Feb 28Drafted as a bill by Insurance and Real Estate Committee
- Mar 1Sent to Insurance and Real Estate Committee
- Mar 7Insurance and Real Estate Committee recommended it and sent it to Appropriations Committee
All 10 actions, as published
- Jan 9REF. TO JOINT COMM. ONBoth houses
- Jan 19Reserved for Subject Matter Public HearingBoth houses
- Feb 2PUBLIC HEARINGBoth houses
- Feb 23Vote to DraftBoth houses
- Feb 28DRAFTED BY COMMITTEEBoth houses
- Mar 1REF. TO JOINT COMM. ONBoth houses
- Mar 7Joint Favorable Change of ReferenceBoth houses
- Mar 8FILED WITH LCOBoth houses
- Mar 10RPTD. OUT OF LCOBoth houses
- Mar 10FAV. CHG. OF REF., SEN. TO COMM. ONSenate